Marcus Altfeld, M.D., Ph.D.
1 clinical trials · Sponsor
◉ Watch Marcus Altfeld, M.D., Ph.D.
| Record | Firm | Date |
|---|---|---|
| Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) (NCT00117429) | Marcus Altfeld, M.D., Ph.D. | 2005-06-01 |
Track Marcus Altfeld, M.D., Ph.D. automatically
Every clearance here is in the API, with alerts when new ones post.